Comment by nickff

The problem is not that one company attempts to raise its prices, the problem is that it is very difficult for competitors to undercut them. The FDA has made it very expensive to introduce and support products in the US pharmaceutical market; it has imposed huge compliance costs, and helped drug companies sustain those costs through exclusivity arrangements.

Moralizing about health issues feels good, but these issues are created by simple economics (market and regulatory issues), not ethical deficiencies.